Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
The role of radiotherapy and immunotherapy with immune checkpoint inhibitors (ICI) is of emerging interest in many solid tumours, including breast cancer. There is increasing evidence that the host’s immune system plays an important role in influencing the response to treatment and prognosis in brea...
Main Authors: | Steven David, Jennifer Tan, Shankar Siva, Lama Karroum, Peter Savas, Sherene Loi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/4/821 |
Similar Items
-
A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
by: Faiez Al-Shafa, et al.
Published: (2019-06-01) -
Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01) -
Stereotactic radiotherapy: An educational narrative review
by: Agha Muhammad Hammad Khan, et al.
Published: (2024-03-01) -
Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
by: Yanhao Liu, et al.
Published: (2021-12-01) -
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
by: Madyson Colton, et al.
Published: (2020-11-01)